DrugDashboards

Market view

remifentanil hydrochloride · Injection, Powder, Lyophilized, For Solution

13 marketed package NDCs · 3 active manufacturers

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “demand increase for the drug.

Same drug class

Other molecules FDA puts in Opioid Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Remifentanil hydrochloride in shortage right now?
Yes. FDA currently lists Remifentanil hydrochloride in shortage, with the reason given as "demand increase for the drug". This page is rebuilt every morning from FDA's shortage database.
Who makes Remifentanil hydrochloride?
7 companies have marketed Remifentanil hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • In shortage nowRemifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)Jun 28, 2022
  • In shortage nowRemifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)Jun 28, 2022
  • In shortage nowRemifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05)Jun 28, 2022
  • In shortage nowRemifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10)Jun 28, 2022
  • In shortage nowRemifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10)Jun 28, 2022
  • In shortage nowRemifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)Jun 28, 2022

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.